Michael Shapiro to Hyperlipidemias
This is a "connection" page, showing publications Michael Shapiro has written about Hyperlipidemias.
Connection Strength
1.025
-
Fazio S, Shapiro MD. Medication-based versus target-based lipid management. J Diabetes. 2018 Oct; 10(10):789-792.
Score: 0.609
-
Ashburn NP, Snavely AC, Rikhi R, Shapiro MD, Chado MA, Ambrosini AP, Biglari AA, Kitchen ST, Millard MJ, Stopyra JP, Mahler SA. Rarely tested or treated but highly prevalent: Hypercholesterolemia in ED observation unit patients with chest pain. Am J Emerg Med. 2023 Sep; 71:47-53.
Score: 0.215
-
Karwatowska-Prokopczuk E, Tardif JC, Gaudet D, Ballantyne CM, Shapiro MD, Moriarty PM, Baum SJ, Amour ES, Alexander VJ, Xia S, Otvos JD, Witztum JL, Tsimikas S. Effect of olezarsen targeting APOC-III on lipoprotein size and particle number measured by NMR in patients with hypertriglyceridemia. J Clin Lipidol. 2022; 16(5):617-625.
Score: 0.201